It is a fixed-dose combination product intended as continuation of therapy in patients with acute coronary syndrome already initiated with separate clopidogrel and aspirin products: Unstable angina or non-ST-elevation myocardial infarction in order to prevent early and long-term atherothrombotic events (myocardial infarction, stroke, vascular death or refractory ischaemia). CoPlavix is indicated for the treatment of acute coronary syndrome whether or not patients undergo cardiac revascularisation (surgical or PCI, with or without stent). ST-segment elevation acute myocardial infarction in order to prevent atherothrombotic events. In this population, CoPlavix has been shown to reduce the rate of death from any cause and the rate of a combined endpoint of death, re-infarction or stroke in medically treated patients eligible for thrombolytic therapy.
Co-Plavix Tablet 75/75mg 10's (clopidogrel)
headaches or dizziness,Nausea,diarrhoea or constipation,indigestion (dyspepsia),stomach ache or abdominal pain,Nosebleeds,increased bleeding (your blood taking longer to clot for example, when you cut yourself), or easy bruising.
Bleeding, Intracranial hemmorhage